NACE Rev. 2.1 · Class · Section C
21.20 Manufacture of pharmaceutical preparations
It includes manufacture of medicaments; manufacture of chemical contraceptive products for external use and hormonal contraceptive medicaments; manufacture of medical diagnostic preparations, including pregnancy tests.
- Level
- Class
- NACE Rev. 2
- 21.20
- TOL 2025 (FI)
- 21200
- Active companies
- 954
What 21.20 covers
Includes
- manufacture of medicaments:
- antisera and other blood fractions
- vaccines
- diverse medicaments, including homeopathic preparations
- manufacture of chemical contraceptive products for external use and hormonal contraceptive medicaments
- manufacture of medical diagnostic preparations, including pregnancy tests
- manufacture of radioactive in-vivo diagnostic substances
- manufacture of cell and gene advanced therapy medical products
Also includes
- manufacture of medical impregnated wadding, gauze, bandages, dressings, etc.
- preparation of botanical products (grinding, grading, milling) for pharmaceutical use
- manufacture of viral vector-based medicines or vaccines
- manufacture of pharmaceutical preparations for veterinary medicines
Classified elsewhere
Excludes
- manufacture of herb infusions (mint, vervain, chamomile, etc.), see 10.83
- manufacture of probiotics, see 21.10
- manufacture of dental cement and other dental fillings, see 32.50
- manufacture of bone reconstruction cements, see 32.50
- manufacture of surgical drapes, see 32.50
- wholesale of pharmaceuticals, see 46.46
- retail sale of pharmaceuticals, see 47.73
- research and development for pharmaceuticals and biotech products, see 72.10
- packaging of pharmaceuticals, see 82.92
Also searched as
- pharma
- pharmaceutical
- drug development
- life sciences
- biotech
- biotechnology
Plain-language terms that lookup_industry maps to this code.
National codes for 21.20
Every EU country uses NACE Rev. 2.1 as its national classification, sometimes with an extra national level. The first four digits of a national code always equal the NACE class, so a company coded under any of the patterns below belongs to 21.20.
| Country | Classification | Code | Local title |
|---|---|---|---|
| France | NAF 2025 INSEE | 21.20A–Z NACE class + 1 letter | Fabrication de préparations pharmaceutiques |
| Sweden | SNI 2025 Statistics Sweden (SCB) | 21200–9 5 digits: NACE class + 1 digit | Tillverkning av läkemedel |
| Belgium | NACE-BEL 2025 Statbel | 21.200–9 5 digits: NACE class + 1 digit | Vervaardiging van farmaceutische producten |
| Czech Republic | CZ-NACE 2025 Czech Statistical Office (ČSÚ) | 2120(0–9) NACE class, some split by a 5th digit | Výroba farmaceutických přípravků |
| Finland | TOL 2025 Statistics Finland | 21200 One subclass | Lääkkeiden valmistus |
| Estonia | EMTAK 2025 Statistics Estonia | 21200–9 5 digits: NACE class + 1 digit | Ravimpreparaatide tootmine |
Local titles are the official NACE Rev. 2.1 translations; national tables can word them slightly differently. Belgium is shown with the Dutch title (French in the translations table).
TOL 2025 subclasses (Finland)
- 21200 Lääkkeiden valmistus Manufacture of pharmaceutical preparations
21.20 in other EU languages
The official title of NACE 21.20 in each language version of NACE Rev. 2.1.
| Language | Title |
|---|---|
| French France (NAF), Belgium (NACE-BEL) | Fabrication de préparations pharmaceutiques |
| German Germany (WZ), Austria (ÖNACE) | Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen |
| Swedish Sweden (SNI) | Tillverkning av läkemedel |
| Finnish Finland (TOL) | Lääkkeiden valmistus |
| Czech Czech Republic (CZ-NACE) | Výroba farmaceutických přípravků |
| Estonian Estonia (EMTAK) | Ravimpreparaatide tootmine |
| Dutch Belgium (NACE-BEL), Netherlands (SBI) | Vervaardiging van farmaceutische producten |
| Danish Denmark (DB) | Fremstilling af farmaceutiske præparater |
| Spanish Spain (CNAE) | Fabricación de especialidades farmacéuticas |
| Italian Italy (ATECO) | Fabbricazione di medicinali e preparati farmaceutici |
| Polish Poland (PKD) | Produkcja leków i pozostałych wyrobów farmaceutycznych |
| Portuguese Portugal (CAE) | Fabricação de preparações farmacêuticas |
What changed from NACE Rev. 2
Unchanged from Rev. 2NACE Rev. 2.1 replaced Rev. 2 in EU statistics from 2025, and national registers are recoding companies to it. These Rev. 2 codes map to 21.20, according to Eurostat’s official correspondence table:
-
Rev. 2 21.20 Manufacture of pharmaceutical preparations maps entirely here
Companies under 21.20
Active legal entities whose main activity is 21.20, from the official business registers. Refreshed daily; sole traders are not included.
Total: 954. A dash means no companies with this main activity in the index yet.
Find 21.20 companies from Claude
EU Company Leads is an MCP server. Your agent resolves the industry with lookup_industry, then lists companies with search_companies, filtered by size, age, region and more.
1 · lookup_industry
{
"query": "pharma"
}
2 · search_companies
{
"nace_codes": [
"21.20"
],
"countries": [
"FR",
"BE"
],
"limit": 25
}
Questions about NACE 21.20
What is NACE 21.20?
NACE 21.20 is the class “Manufacture of pharmaceutical preparations” in NACE Rev. 2.1, the EU statistical classification of economic activities, part of group 21.2 (Manufacture of pharmaceutical preparations), in division 21 (Manufacture of basic pharmaceutical products and pharmaceutical preparations), in section C (Manufacturing). It includes manufacture of medicaments; manufacture of chemical contraceptive products for external use and hormonal contraceptive medicaments; manufacture of medical diagnostic preparations, including pregnancy tests.
Which NACE code is used for manufacture of herb infusions (mint, vervain, chamomile, etc.)?
Manufacture of herb infusions (mint, vervain, chamomile, etc.) is classified in NACE 10.83 (Processing of tea and coffee), not in 21.20, according to the Eurostat explanatory notes for NACE Rev. 2.1.
Which NACE code is used for manufacture of probiotics?
Manufacture of probiotics is classified in NACE 21.10 (Manufacture of basic pharmaceutical products), not in 21.20, according to the Eurostat explanatory notes for NACE Rev. 2.1.
Which NACE code is used for manufacture of dental cement and other dental fillings?
Manufacture of dental cement and other dental fillings is classified in NACE 32.50 (Manufacture of medical and dental instruments and supplies), not in 21.20, according to the Eurostat explanatory notes for NACE Rev. 2.1.
What is the national equivalent of NACE 21.20 in France, Sweden, Belgium, Czech Republic, Finland and Estonia?
All six keep the NACE class 21.20 and add at most one national position. NAF 2025 (France) writes it as 21.20 followed by one letter; SNI 2025 (Sweden), NACE-BEL 2025 (Belgium) and EMTAK 2025 (Estonia) use five digits beginning with 2120; CZ-NACE 2025 (Czech Republic) uses 2120, split by a fifth digit in some classes; TOL 2025 (Finland) uses 21200. The first four digits always equal the NACE class.
What was the NACE Rev. 2 code for NACE 21.20?
The code is unchanged: NACE Rev. 2 21.20 (Manufacture of pharmaceutical preparations) maps one-to-one to 21.20 in NACE Rev. 2.1.
How many companies are registered under NACE 21.20?
EU Company Leads holds 954 active companies whose main activity is 21.20: France 533, Belgium 176, Sweden 135, Finland 46, Czech Republic 43, Estonia 21. Counts come from the official business registers and are refreshed daily; sole traders are not included.
Headings, explanatory notes, translations and the Rev. 2 → Rev. 2.1 correspondence: © European Union, Eurostat, NACE Rev. 2.1, licensed under CC BY 4.0; formatted and linked by EU Company Leads. TOL 2025 subclasses: Statistics Finland, CC BY 4.0. Company counts: official national business registers.